title: [Pregnancy under immunosuppression].
abstract: The desire to have children and pregnancy itself are important topics in the treatment of patients under immunosuppression. In this review the risks of frequently prescribed immunosuppressants are discussed regarding the safety of mother and child during and after pregnancy. Knowledge of the specific risks of immunosuppressants in pregnancy is important to balance the therapy between the patients' desire to be treated most effectively and to deliver a healthy child after an uncomplicated pregnancy. Generally, an interdisciplinary approach is advisable in treating and counseling immunosuppressed patients with a desire to have children and during pregnancy.
authors.affiliation: Klinik und Poliklinik für Innere Medizin I, Universitätsklinikum Halle, Ernst-Grube-Straße 40, 06120, Halle, Deutschland. Jens.Walldorf@medizin.uni-halle.de
authors.forename: J
authors.initials: J
authors.lastname: Walldorf
authors.forename: M M
authors.initials: MM
authors.lastname: Dollinger
authors.forename: T
authors.initials: T
authors.lastname: Seufferlein
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000517:prevention & control; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000276:immunology*; D003299:Cooperative Behavior; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007231:Infant, Newborn; D007249:Inflammation / Q000188:drug therapy* / Q000276:immunology*; D033183:Interdisciplinary Communication; D016377:Organ Transplantation; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000276:immunology*; D018566:Pregnancy, High-Risk; D014181:Transplantation Immunology / Q000187:drug effects
chemical_list: D007166:Immunosuppressive Agents